Search for: "Teva Pharmaceuticals" Results 401 - 420 of 1,423
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2018, 2:25 am
  There has not been any decision from the French Supreme Court on the requirement for sufficiency of disclosure applicable to pharmaceutical patents since 1992 and none relating to second medical use claims. [read post]
7 Jan 2018, 12:47 pm by Simon Holzer
Mepha, a Swiss subsidiary of Teva, sought a declaration of invalidity of Gilead’s Swiss SPC. [read post]
28 Dec 2017, 2:44 am by Neil Wilkof
To this list the name of the Israeli company Teva Pharmaceutical Industries should be added; in some ways, Teva's story may be the most emotional of all. [read post]
19 Dec 2017, 11:46 am by Kenneth Hall
Following the lead of other states [JURIST report] and municipalities [JURIST report], the 153-page complaint alleges that numerous manufactures and distributors of opioids, including Purdue Pharma, Teva Pharmaceuticals, McKesson, CVS, Walgreens, Rite Aid and Costco, have ignored the dangerous effects of the drugs... [read post]
11 Dec 2017, 5:16 pm by Aurora Barnes
The petition of the day is: Teva Pharmaceuticals USA, Inc. v. [read post]
30 Nov 2017, 11:11 am
The AmeriKat is no longer in the dark about whatthe Dutch Supreme Court were saying inMSD v TevaThanks to a wonderful Kat friend, readers can now benefit from the translation of the recent Dutch Supreme Court's decision in MSD v Teva (as reported here). [read post]
21 Nov 2017, 1:25 pm by Overhauser Law Offices, LLC
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana, filed suit in the Southern District of Indiana alleging that Defendants, Actavis LLC of Parsippany, New Jersey; Teva Pharmaceuticals USA of North Wales, Pennsylvania; and Teva Pharmaceutical Industries, Ltd. of Petach Tikva, Israel infringed its rights in United States Patent No. 7,772,209 (“the ’209 patent”) for “Antifolate Combination… [read post]
5 Nov 2017, 3:10 pm
  Actavis and Teva appealed the decision on the '181 Patent on five grounds - construction/infringement, lack of entitlement to priority, added matter, novelty and obviousness. [read post]
4 Nov 2017, 5:47 am
The case concerned the use of ribavirin for the manufacturer of  a pharmaceutical composition for treating a specific sub-group (the G1N-subgroup) of HCV patients suffering with chronic hepatitis. [read post]
30 Oct 2017, 4:00 am by Administrator
… Legal FeedsSCC rules banks liable for Teva employee’s fraud scheme The Supreme Court of Canada has ruled that two banks were liable for a $5.5-million cheque fraud carried out by a former employee of Teva Canada Ltd. [read post]
25 Oct 2017, 9:02 am
Switzerland was not part of the EU regulatory framework for the approval of pharmaceuticals. [read post]
25 Oct 2017, 6:55 am by Overhauser Law Offices, LLC
Other petitioners joined in the case are Apotex, Inc, Teva Pharmaceuticals USA, Fresenius Kabi USA, and Wockhardt Bio AG. [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
17 Oct 2017, 8:15 am by Gene Quinn
Bryson of the United States Federal District Court for the Eastern District of Texas found that Allergan's RESTASIS® patents were infringed by Teva Pharmaceuticals USA, but that Teva had demonstrated invalidity of those patents by clear and convincing evidence... [read post]